Physician profile

Susan E Uhrich

Psychiatry · Lafayette, LA

NPI 1619182045

$1,143.67

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Allergan, INC. $218.56 2019
Avanir Pharmaceuticals, INC. $169.54 2019-2021
Teva Pharmaceuticals USA, INC. $146.58 2019
Indivior INC. $115.29 2019
Lundbeck LLC $77.93 2019
Alkermes, INC. $72.70 2019-2021
Neurocrine Biosciences, INC. $70.35 2019
Sunovion Pharmaceuticals INC. $57.48 2019
Ironshore Pharmaceuticals INC. $44.34 2019-2022
Takeda Pharmaceuticals U.S.A., INC. $34.60 2019
Vanda Pharmaceuticals INC. $30.95 2019
Otsuka America Pharmaceutical, INC. $23.02 2019
Neos Therapeutics, LP $21.95 2019
Shire North American Group INC $18.77 2019
Jazz Pharmaceuticals INC. $14.21 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Orexo US, INC. $13.97 2019
Janssen Pharmaceuticals, INC $13.43 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Susan E Uhrich

$1,143.67

in general payments reported 2019-2025

Years
2019-2022
Top company
Allergan, INC.

https://glasscript.com/doctor/409286/susan-e-uhrich

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.